ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Artemisinin Antimalarial Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-0X8200
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Artemisinin Antimalarial Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Artemisinin Antimalarial Drugs Market Research Report 2025

Code: QYRE-Auto-0X8200
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Sanofi
Ajanta
Cipla Ltd
Ipca
Guilin Medicine
GlaxoSmithKline PLC
Mylan Labs
Roche

Artemisinin Antimalarial Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Artemisinin Antimalarial Drugs Market

Artemisinin Antimalarial Drugs Market

The global market for Artemisinin Antimalarial Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Artemisinin Antimalarial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin Antimalarial Drugs.
The Artemisinin Antimalarial Drugs market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Artemisinin Antimalarial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin Antimalarial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Artemisinin Antimalarial Drugs Market Report

Report Metric Details
Report Name Artemisinin Antimalarial Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Prevention
  • Treatment
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Sanofi, Ajanta, Cipla, Ipca, Guilin Medicine, GlaxoSmithKline, Mylan Labs, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Artemisinin Antimalarial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Artemisinin Antimalarial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Artemisinin Antimalarial Drugs Market report?

Ans: The main players in the Artemisinin Antimalarial Drugs Market are Novartis, Sanofi, Ajanta, Cipla, Ipca, Guilin Medicine, GlaxoSmithKline, Mylan Labs, Roche

What are the Application segmentation covered in the Artemisinin Antimalarial Drugs Market report?

Ans: The Applications covered in the Artemisinin Antimalarial Drugs Market report are Prevention, Treatment, Other

What are the Type segmentation covered in the Artemisinin Antimalarial Drugs Market report?

Ans: The Types covered in the Artemisinin Antimalarial Drugs Market report are Artesunate, Dihydroartemisinin, Artemether

Recommended Reports

Antimalarial & Anti-Infective

Pharmaceutical Services

General Therapeutics

1 Artemisinin Antimalarial Drugs Market Overview
1.1 Product Definition
1.2 Artemisinin Antimalarial Drugs by Type
1.2.1 Global Artemisinin Antimalarial Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Artesunate
1.2.3 Dihydroartemisinin
1.2.4 Artemether
1.3 Artemisinin Antimalarial Drugs by Application
1.3.1 Global Artemisinin Antimalarial Drugs Market Value by Application (2024 VS 2031)
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 Global Artemisinin Antimalarial Drugs Market Size Estimates and Forecasts
1.4.1 Global Artemisinin Antimalarial Drugs Revenue 2020-2031
1.4.2 Global Artemisinin Antimalarial Drugs Sales 2020-2031
1.4.3 Global Artemisinin Antimalarial Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Artemisinin Antimalarial Drugs Market Competition by Manufacturers
2.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Artemisinin Antimalarial Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Artemisinin Antimalarial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artemisinin Antimalarial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artemisinin Antimalarial Drugs, Product Type & Application
2.7 Global Key Manufacturers of Artemisinin Antimalarial Drugs, Date of Enter into This Industry
2.8 Global Artemisinin Antimalarial Drugs Market Competitive Situation and Trends
2.8.1 Global Artemisinin Antimalarial Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Artemisinin Antimalarial Drugs Players Market Share by Revenue
2.8.3 Global Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Artemisinin Antimalarial Drugs Market Scenario by Region
3.1 Global Artemisinin Antimalarial Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Artemisinin Antimalarial Drugs Sales by Region: 2020-2031
3.2.1 Global Artemisinin Antimalarial Drugs Sales by Region: 2020-2025
3.2.2 Global Artemisinin Antimalarial Drugs Sales by Region: 2026-2031
3.3 Global Artemisinin Antimalarial Drugs Revenue by Region: 2020-2031
3.3.1 Global Artemisinin Antimalarial Drugs Revenue by Region: 2020-2025
3.3.2 Global Artemisinin Antimalarial Drugs Revenue by Region: 2026-2031
3.4 North America Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.4.1 North America Artemisinin Antimalarial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Artemisinin Antimalarial Drugs Sales by Country (2020-2031)
3.4.3 North America Artemisinin Antimalarial Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.5.1 Europe Artemisinin Antimalarial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Artemisinin Antimalarial Drugs Sales by Country (2020-2031)
3.5.3 Europe Artemisinin Antimalarial Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artemisinin Antimalarial Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Artemisinin Antimalarial Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Artemisinin Antimalarial Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.7.1 Latin America Artemisinin Antimalarial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Artemisinin Antimalarial Drugs Sales by Country (2020-2031)
3.7.3 Latin America Artemisinin Antimalarial Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Artemisinin Antimalarial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artemisinin Antimalarial Drugs Sales by Type (2020-2031)
4.1.1 Global Artemisinin Antimalarial Drugs Sales by Type (2020-2025)
4.1.2 Global Artemisinin Antimalarial Drugs Sales by Type (2026-2031)
4.1.3 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2020-2031)
4.2 Global Artemisinin Antimalarial Drugs Revenue by Type (2020-2031)
4.2.1 Global Artemisinin Antimalarial Drugs Revenue by Type (2020-2025)
4.2.2 Global Artemisinin Antimalarial Drugs Revenue by Type (2026-2031)
4.2.3 Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Artemisinin Antimalarial Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Artemisinin Antimalarial Drugs Sales by Application (2020-2031)
5.1.1 Global Artemisinin Antimalarial Drugs Sales by Application (2020-2025)
5.1.2 Global Artemisinin Antimalarial Drugs Sales by Application (2026-2031)
5.1.3 Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2020-2031)
5.2 Global Artemisinin Antimalarial Drugs Revenue by Application (2020-2031)
5.2.1 Global Artemisinin Antimalarial Drugs Revenue by Application (2020-2025)
5.2.2 Global Artemisinin Antimalarial Drugs Revenue by Application (2026-2031)
5.2.3 Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Artemisinin Antimalarial Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Artemisinin Antimalarial Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Artemisinin Antimalarial Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Ajanta
6.3.1 Ajanta Company Information
6.3.2 Ajanta Description and Business Overview
6.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ajanta Artemisinin Antimalarial Drugs Product Portfolio
6.3.5 Ajanta Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Company Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Artemisinin Antimalarial Drugs Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Ipca
6.5.1 Ipca Company Information
6.5.2 Ipca Description and Business Overview
6.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ipca Artemisinin Antimalarial Drugs Product Portfolio
6.5.5 Ipca Recent Developments/Updates
6.6 Guilin Medicine
6.6.1 Guilin Medicine Company Information
6.6.2 Guilin Medicine Description and Business Overview
6.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolio
6.6.5 Guilin Medicine Recent Developments/Updates
6.7 GlaxoSmithKline
6.7.1 GlaxoSmithKline Company Information
6.7.2 GlaxoSmithKline Description and Business Overview
6.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Mylan Labs
6.8.1 Mylan Labs Company Information
6.8.2 Mylan Labs Description and Business Overview
6.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Labs Artemisinin Antimalarial Drugs Product Portfolio
6.8.5 Mylan Labs Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Artemisinin Antimalarial Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artemisinin Antimalarial Drugs Industry Chain Analysis
7.2 Artemisinin Antimalarial Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artemisinin Antimalarial Drugs Production Mode & Process Analysis
7.4 Artemisinin Antimalarial Drugs Sales and Marketing
7.4.1 Artemisinin Antimalarial Drugs Sales Channels
7.4.2 Artemisinin Antimalarial Drugs Distributors
7.5 Artemisinin Antimalarial Drugs Customer Analysis
8 Artemisinin Antimalarial Drugs Market Dynamics
8.1 Artemisinin Antimalarial Drugs Industry Trends
8.2 Artemisinin Antimalarial Drugs Market Drivers
8.3 Artemisinin Antimalarial Drugs Market Challenges
8.4 Artemisinin Antimalarial Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Sanofi
Ajanta
Cipla Ltd
Ipca
Guilin Medicine
GlaxoSmithKline PLC
Mylan Labs
Roche
List of Tables
 Table 1. Global Artemisinin Antimalarial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Artemisinin Antimalarial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Artemisinin Antimalarial Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Artemisinin Antimalarial Drugs Sales (KG) of Key Manufacturers (2020-2025)
 Table 5. Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Artemisinin Antimalarial Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Artemisinin Antimalarial Drugs Average Price (US$/G) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Artemisinin Antimalarial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Artemisinin Antimalarial Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Artemisinin Antimalarial Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Artemisinin Antimalarial Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Artemisinin Antimalarial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Antimalarial Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Artemisinin Antimalarial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Artemisinin Antimalarial Drugs Sales by Region (2020-2025) & (KG)
 Table 18. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Artemisinin Antimalarial Drugs Sales by Region (2026-2031) & (KG)
 Table 20. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Artemisinin Antimalarial Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Artemisinin Antimalarial Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Artemisinin Antimalarial Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Artemisinin Antimalarial Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Artemisinin Antimalarial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Artemisinin Antimalarial Drugs Sales by Country (2020-2025) & (KG)
 Table 27. North America Artemisinin Antimalarial Drugs Sales by Country (2026-2031) & (KG)
 Table 28. North America Artemisinin Antimalarial Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Artemisinin Antimalarial Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Artemisinin Antimalarial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Artemisinin Antimalarial Drugs Sales by Country (2020-2025) & (KG)
 Table 32. Europe Artemisinin Antimalarial Drugs Sales by Country (2026-2031) & (KG)
 Table 33. Europe Artemisinin Antimalarial Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Artemisinin Antimalarial Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Artemisinin Antimalarial Drugs Sales by Region (2020-2025) & (KG)
 Table 37. Asia Pacific Artemisinin Antimalarial Drugs Sales by Region (2026-2031) & (KG)
 Table 38. Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Artemisinin Antimalarial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Artemisinin Antimalarial Drugs Sales by Country (2020-2025) & (KG)
 Table 42. Latin America Artemisinin Antimalarial Drugs Sales by Country (2026-2031) & (KG)
 Table 43. Latin America Artemisinin Antimalarial Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Artemisinin Antimalarial Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Artemisinin Antimalarial Drugs Sales by Country (2020-2025) & (KG)
 Table 47. Middle East and Africa Artemisinin Antimalarial Drugs Sales by Country (2026-2031) & (KG)
 Table 48. Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Artemisinin Antimalarial Drugs Sales (KG) by Type (2020-2025)
 Table 51. Global Artemisinin Antimalarial Drugs Sales (KG) by Type (2026-2031)
 Table 52. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Artemisinin Antimalarial Drugs Price (US$/G) by Type (2020-2025)
 Table 59. Global Artemisinin Antimalarial Drugs Price (US$/G) by Type (2026-2031)
 Table 60. Global Artemisinin Antimalarial Drugs Sales (KG) by Application (2020-2025)
 Table 61. Global Artemisinin Antimalarial Drugs Sales (KG) by Application (2026-2031)
 Table 62. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Artemisinin Antimalarial Drugs Price (US$/G) by Application (2020-2025)
 Table 69. Global Artemisinin Antimalarial Drugs Price (US$/G) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 73. Novartis Artemisinin Antimalarial Drugs Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 78. Sanofi Artemisinin Antimalarial Drugs Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Ajanta Company Information
 Table 81. Ajanta Description and Business Overview
 Table 82. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 83. Ajanta Artemisinin Antimalarial Drugs Product
 Table 84. Ajanta Recent Developments/Updates
 Table 85. Cipla Company Information
 Table 86. Cipla Description and Business Overview
 Table 87. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 88. Cipla Artemisinin Antimalarial Drugs Product
 Table 89. Cipla Recent Developments/Updates
 Table 90. Ipca Company Information
 Table 91. Ipca Description and Business Overview
 Table 92. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 93. Ipca Artemisinin Antimalarial Drugs Product
 Table 94. Ipca Recent Developments/Updates
 Table 95. Guilin Medicine Company Information
 Table 96. Guilin Medicine Description and Business Overview
 Table 97. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 98. Guilin Medicine Artemisinin Antimalarial Drugs Product
 Table 99. Guilin Medicine Recent Developments/Updates
 Table 100. GlaxoSmithKline Company Information
 Table 101. GlaxoSmithKline Description and Business Overview
 Table 102. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 103. GlaxoSmithKline Artemisinin Antimalarial Drugs Product
 Table 104. GlaxoSmithKline Recent Developments/Updates
 Table 105. Mylan Labs Company Information
 Table 106. Mylan Labs Description and Business Overview
 Table 107. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 108. Mylan Labs Artemisinin Antimalarial Drugs Product
 Table 109. Mylan Labs Recent Developments/Updates
 Table 110. Roche Company Information
 Table 111. Roche Description and Business Overview
 Table 112. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
 Table 113. Roche Artemisinin Antimalarial Drugs Product
 Table 114. Roche Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Artemisinin Antimalarial Drugs Distributors List
 Table 118. Artemisinin Antimalarial Drugs Customers List
 Table 119. Artemisinin Antimalarial Drugs Market Trends
 Table 120. Artemisinin Antimalarial Drugs Market Drivers
 Table 121. Artemisinin Antimalarial Drugs Market Challenges
 Table 122. Artemisinin Antimalarial Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Artemisinin Antimalarial Drugs
 Figure 2. Global Artemisinin Antimalarial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Artemisinin Antimalarial Drugs Market Share by Type: 2024 & 2031
 Figure 4. Artesunate Product Picture
 Figure 5. Dihydroartemisinin Product Picture
 Figure 6. Artemether Product Picture
 Figure 7. Global Artemisinin Antimalarial Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Artemisinin Antimalarial Drugs Market Share by Application: 2024 & 2031
 Figure 9. Prevention
 Figure 10. Treatment
 Figure 11. Other
 Figure 12. Global Artemisinin Antimalarial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Artemisinin Antimalarial Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Artemisinin Antimalarial Drugs Sales (2020-2031) & (KG)
 Figure 15. Global Artemisinin Antimalarial Drugs Average Price (US$/G) & (2020-2031)
 Figure 16. Artemisinin Antimalarial Drugs Report Years Considered
 Figure 17. Artemisinin Antimalarial Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Artemisinin Antimalarial Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Artemisinin Antimalarial Drugs Players: Market Share by Revenue in Artemisinin Antimalarial Drugs in 2024
 Figure 20. Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Artemisinin Antimalarial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Artemisinin Antimalarial Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Artemisinin Antimalarial Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Artemisinin Antimalarial Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Artemisinin Antimalarial Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Artemisinin Antimalarial Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Artemisinin Antimalarial Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Artemisinin Antimalarial Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Artemisinin Antimalarial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Artemisinin Antimalarial Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Artemisinin Antimalarial Drugs by Type (2020-2031)
 Figure 56. Global Artemisinin Antimalarial Drugs Price (US$/G) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Artemisinin Antimalarial Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Artemisinin Antimalarial Drugs by Application (2020-2031)
 Figure 59. Global Artemisinin Antimalarial Drugs Price (US$/G) by Application (2020-2031)
 Figure 60. Artemisinin Antimalarial Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Malaria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artesunate API Market Research Report 2025
Antiparasitic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artemether API Market Research Report 2025
Global Ant Killer Market Research Report 2024
Hydroxychloroquine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chloroquine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Antimania Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti tuberculosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Infectives Market Research Report 2025
Rat Poison Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiallergics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nikethamide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions